[1]
“Initial Clinical Experience with Established and Novel Radiopharmaceuticals for Radionuclide Therapy”, Вопр. онкол., vol. 71, no. 5, p. OF-2250, Nov. 2025, doi: 10.37469/0507-3758-2025-71-5-OF-2250.